Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma

PaperCitations, authors & open-access status

Low Dose of Human scFv-Derived BCMA-Targeted CAR-T Cells Achieved Fast Response and High Complete Remission in Patients with Relapsed/Refractory Multiple Myeloma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 50 citations, 2018 year and closed oa status.

50
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Songfu Jiang
Author
Kang Yu
Author
Blood
Journal
CAR-T cell therapy research
Topic
CAR-T cell therapy research
Topic
470M+ articles · free account